C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2011
10/25/2011	US8044265 Gene promotors which can be used in plants
10/25/2011	US8044193 Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
10/25/2011	US8044192 Trichoderma promoter
10/25/2011	US8044191 Using expression vector comprising nucleotide sequences coding elongation factor regulatory sequences as high efficiency gene transfer tool
10/25/2011	US8044189 Bacillus anthracis protective antigen nucleic acid sequences
10/25/2011	US8044186 Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering
10/25/2011	US8044185 Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
10/25/2011	US8044184 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
10/25/2011	US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011	US8043851 DNA encoding a neoculin acidic subunit of curculin
10/25/2011	US8043850 Fluorescent protein and gene encoding the same
10/25/2011	US8043841 Nucleic acid molecules encoding alanine 2,3-aminomutases
10/25/2011	US8043839 Xylanases, nucleic acids encoding them and methods for making and using them
10/25/2011	US8043837 Aldolases, nucleic acids encoding them and methods for making and using them
10/25/2011	US8043835 Methods for detecting and monitoring cancer using extracellular RNA
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043829 DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
10/25/2011	US8043827 Single molecule-format real-time bioluminescence imaging probe
10/25/2011	US8043813 Method of detecting H5 or H7 avian influenza virus
10/25/2011	US8043811 Purification method and kits
10/25/2011	US8043810 Analyte detection using autocatalytic chain reactions
10/25/2011	US8043809 Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs
10/25/2011	US8043807 Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
10/25/2011	US8043805 Detection of high grade dysplasia in cervical cells
10/25/2011	US8043802 Fluorescence based biosensor
10/25/2011	US8043801 Method of screening for agents to treat heart failure
10/25/2011	US8043638 Mutant ILV5 gene and use thereof
10/25/2011	US8043622 Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
10/25/2011	CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/25/2011	CA2435551C Families of non-cross-hybridizing polynucleotides for use as tags and tag complements, manufacture and use thereof
10/20/2011	WO2011130624A2 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
10/20/2011	WO2011130577A1 Controlled polyplex assembly
10/20/2011	WO2011130557A2 Phosphonates with reduced toxicity for treatment of viral infections
10/20/2011	WO2011130498A1 Micrornas that chemosensitize the apoptotic effect of 17-aag
10/20/2011	WO2011130273A2 Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkers
10/20/2011	WO2011130195A1 APTAMERS TO β-NGF AND THEIR USE IN TREATING β-NGF MEDIATED DISEASES AND DISORDERS
10/20/2011	WO2011106696A3 Compositions and methods for the production of l-homoalanine
10/20/2011	WO2011098979A3 Radioresistant alga of the coccomyxa genus
10/20/2011	WO2011094546A3 Oligonucleotides which inhibit p53 induction in response to cellular stress
10/20/2011	US20110258742 Stress Tolerant Transgenic Crop Plants
10/20/2011	US20110258739 Polynucleotide sequence of fruit softening associated b-d-n- acetylhexosaminidase and its uses for enhancing fruit shelf life
10/20/2011	US20110258738 Tor-interacting proteins (tips) and genes therefor
10/20/2011	US20110258717 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof
10/20/2011	US20110258714 Phytase variants
10/20/2011	US20110257385 Methods for flip-strand immobilizing and sequencing nucleic acids
10/20/2011	US20110257384 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/20/2011	US20110257383 Rna complexes, methods of their production
10/20/2011	US20110257374 Novel Reagents for Directed Biomarker Signal Amplification
10/20/2011	US20110257373 Ligands that have binding specificity for dc-sign
10/20/2011	US20110257252 Novel antithrombotic diadenosine tetraphosphates and related analogs
10/20/2011	US20110257251 Telomerase inhibitors and methods of use thereof
10/20/2011	US20110257248 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
10/20/2011	US20110257247 Method of Treating Neurodegenerative Disease
10/20/2011	US20110257098 Compositions and methods for treating growth hormone deficiency
10/20/2011	US20110257083 Msp-1 protein preparations from plasmodium
10/20/2011	US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011	US20110257043 Ultra high-throughput opti-nanopore dna readout platform
10/20/2011	US20110257031 Nucleic acid, biomolecule and polymer identifier codes
10/20/2011	US20110257027 Gamma-secretase substrate and methods of use
10/20/2011	US20110256637 Target Detection Using a Single-Stranded, Self-Complementary, Triple-Stem DNA Probe
10/20/2011	US20110256620 Nucleic acid encoding a self-assembling split-fluorescent protein system
10/20/2011	US20110256611 Interferon beta production promoter and a method for producing thereof
10/20/2011	US20110256609 Compositions And Methods Comprising Variant Microbial Proteases
10/20/2011	US20110256607 Homing endonucleases
10/20/2011	US20110256601 Modification of hydrogenase activities in thermophilic bacteria to enhance ethanol production
10/20/2011	US20110256589 T7 rna polymerase variants with enhanced thermostability
10/20/2011	US20110256587 High affinity human antibodies to human nerve growth factor
10/20/2011	US20110256586 Methods and Compositions for the Prevention and Treatment of Anemia
10/20/2011	US20110256585 Mutant penicillin g acylases
10/20/2011	US20110256571 Proteins
10/20/2011	US20110256546 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	US20110256545 mRNA expression-based prognostic gene signature for non-small cell lung cancer
10/20/2011	US20110256544 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
10/20/2011	US20110256543 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
10/20/2011	US20110256537 Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkers
10/20/2011	US20110256536 Two stage nucleic acid amplification using an amplification oligomer
10/20/2011	US20110256535 Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin
10/20/2011	US20110256534 Prediction of antiviral therapy response
10/20/2011	US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
10/20/2011	US20110256530 Products and methods for tissue preservation
10/20/2011	US20110256182 Genes encoding major capsid protein l1 of human papilloma virus
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256163 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
10/20/2011	US20110256158 Novel use of an il-12 receptor splice variant and molecular assay to quantify expression thereof
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256154 Anti-erbb3 antibodies
10/20/2011	US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256138 Amyloid-beta binding proteins
10/20/2011	US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam
10/20/2011	US20110256133 Anti-polyubiquitin antibodies and methods of use
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256127 Anti-lrp6 antibodies
10/20/2011	US20110256120 Methods and Compositions for Reducing Amyloid Beta Levels
10/20/2011	US20110256119 Novel uses of grs proteins or fragments thereof
10/20/2011	US20110256112 Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein
10/20/2011	US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof

1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 899